A novel erythromycin resistance methylase gene (ermTR) in Streptococcus pyogenes

被引:0
|
作者
Seppälä, H
Skurnik, M
Soini, H
Roberts, MC
Huovinen, P
机构
[1] Natl Publ Hlth Inst, Antimicrobial Res Lab, Turku 20520, Finland
[2] Natl Publ Hlth Inst, Mycobacterial Reference Lab, Turku 20520, Finland
[3] Univ Turku, Turku Ctr biotechnol, Turku 20521, Finland
[4] Abo Akad Univ, Turku 20521, Finland
[5] Univ Washington, Sch Publ Hlth & Community Med, Dept Pathobiol, Seattle, WA 98195 USA
关键词
D O I
暂无
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Erythromycin resistance among streptococci is commonly due to target site modification by an rRNA-methylating enzyme, which results in coresistance to macrolide, lincosamide, and streptogramin B antibiotics (MLSB resistance), Genes belonging to the ermAM (ermB) gene class are the only erythromycin resistance methylase (erm) genes in Streptococcus pyogenes with MLSB resistance that have been sequenced so far, We identified a novel erm gene, designated ermTR, from an erythromycin-resistant clinical strain of S. pyogenes (strain A200) with an inducible type of MLSB resistance. The nucleotide sequence of ermTR is 82.5% identical to ermA, previously found, for example, in Staphylococcus aureus and coagulase-negative staphylococci. Our finding provides the first sequence of an erm gene other than ermAM that mediates MLSB resistance in S. pyogenes.
引用
收藏
页码:257 / 262
页数:6
相关论文
共 50 条
  • [1] Cloned ermTR Gene Confers Low Level Erythromycin But High Level Clindamycin Resistance in Streptococcus pyogenes NZ131
    Oryasin, Erman
    Biyik, Haci Halil
    Tristram, Stephen
    Bozdogan, Bulent
    MICROBIAL DRUG RESISTANCE, 2020, 26 (07) : 747 - 751
  • [2] Streptococcus pyogenes erythromycin resistance in Italy
    Bassetti, M
    Mantero, E
    Gatti, G
    Di Biagio, A
    Bassetti, D
    EMERGING INFECTIOUS DISEASES, 1999, 5 (02) : 302 - 303
  • [3] Erythromycin resistance in Streptococcus pyogenes in Italy
    Bassetti, M
    Manno, G
    Collidà, A
    Ferrando, A
    Gatti, G
    Ugolotti, U
    Cruciani, M
    Bassetti, D
    EMERGING INFECTIOUS DISEASES, 2000, 6 (02) : 180 - 183
  • [4] Erythromycin resistance of Streptococcus pyogenes in Madrid
    Orden, B
    Perez-Trallero, E
    Montes, M
    Martínez, R
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1998, 17 (06) : 470 - 473
  • [5] Identification of an erm(A) erythromycin resistance methylase gene in Streptococcus pneumoniae isolated in Greece
    Syrogiannopoulos, GA
    Grivea, IN
    Tait-Kamradt, A
    Katopodis, GD
    Beratis, NG
    Sutcliffe, J
    Appelbaum, PC
    Davies, TA
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (01) : 342 - 344
  • [6] RELATIVE ERYTHROMYCIN RESISTANCE IN STREPTOCOCCUS-PYOGENES
    BOTHA, P
    SOUTH AFRICAN MEDICAL JOURNAL, 1990, 77 (09): : 486 - 487
  • [7] Macrolide prescriptions and erythromycin resistance of Streptococcus pyogenes
    Gagliotti, C
    Nobilio, L
    Milandri, M
    Moro, ML
    CLINICAL INFECTIOUS DISEASES, 2006, 42 (08) : 1153 - 1156
  • [8] Resistance of Streptococcus pyogenes to erythromycin and related antibiotics in Italy
    Cornaglia, G
    Ligozzi, M
    Mazzariol, A
    Masala, L
    Lo Cascio, G
    Orefici, G
    Fontana, R
    CLINICAL INFECTIOUS DISEASES, 1998, 27 : S87 - S92
  • [9] Utilisation of macrolides and the development of Streptococcus pyogenes resistance to erythromycin
    Karel Urbánek
    Milan Kolář
    Luboslava Čekanová
    Pharmacy World and Science, 2005, 27 : 104 - 107
  • [10] Utilisation of macrolides and the development of Streptococcus pyogenes resistance to erythromycin
    Urbánek, K
    Kolár, M
    Cekanová, L
    PHARMACY WORLD & SCIENCE, 2005, 27 (02): : 104 - 107